News Update: Amgen Recalls Anemia Drugs Due To Glass Flakes

"Amgen (NASDAQ:AMGN) announced Friday that it was recalling certain lots of its anemia drug Procrit and Epogen due to concerns that glass from the inside of drug's vial could flake off over time.

Amgen sells Epogen in the US and Johnson & Johnson (NYSE:JNJ) unit Centocor distributes Procrit in the US.

Amgen said, thus far, no adverse occurrences have been called in, but that glass flakes in the drug could generate blood clots.

SmarTrend is bullish on shares of Amgen and our subscribers were alerted to buy on September 10, 2010 at $54.16. The stock has risen 3.5% since the alert was issued."

Category:

News & Politics

Tags:

• Amgen
• AMGN
• anemia
• drug
• Procrit
• Epogen
• Johnson
• JNJ
• SmarTrend
• Investment
• News